Efficacy News and Research

RSS
Vaccines remain the most effective way to protect against COVID-19 Delta variant, study says

Vaccines remain the most effective way to protect against COVID-19 Delta variant, study says

Existing drugs block or reduce SARS-CoV2 infection in cells

Existing drugs block or reduce SARS-CoV2 infection in cells

Durable highly protective T cell response to AAV-spike vaccine against COVID-19 pneumonia in mice

Durable highly protective T cell response to AAV-spike vaccine against COVID-19 pneumonia in mice

Early clinical trial data in for whole virus COVID-19 vaccine candidate

Early clinical trial data in for whole virus COVID-19 vaccine candidate

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

Vaccine nationalism may increase COVID-19 case numbers and the emergence of novel variants

Vaccine nationalism may increase COVID-19 case numbers and the emergence of novel variants

Researchers create the first 3D-bioprinted model of active glioblastoma tumor

Researchers create the first 3D-bioprinted model of active glioblastoma tumor

Genomic surveillance is vital to combat COVID-19

Genomic surveillance is vital to combat COVID-19

Severe COVID-19 characterized by phosphorylation of STAT1

Severe COVID-19 characterized by phosphorylation of STAT1

Videos capture the inexorable spread of SARS-CoV-2 in live animals

Videos capture the inexorable spread of SARS-CoV-2 in live animals

Convalescent plasma does not benefit high-risk COVID-19 outpatients with early symptoms, study shows

Convalescent plasma does not benefit high-risk COVID-19 outpatients with early symptoms, study shows

The White House says boosters for all. Here’s what you need to know.

The White House says boosters for all. Here’s what you need to know.

Study examines prevalence of neutralizing antibodies to HCoV-NL63 in healthy adults in Australia

Study examines prevalence of neutralizing antibodies to HCoV-NL63 in healthy adults in Australia

Rush to boosters sparks confusion, differing recommendations

Rush to boosters sparks confusion, differing recommendations

Children’s Hospital Colorado helps prove safety and efficacy of CF treatment in younger pediatric patients

Children’s Hospital Colorado helps prove safety and efficacy of CF treatment in younger pediatric patients

New nanobiotechnology shows remarkable ability to battle dangerous fungal infections

New nanobiotechnology shows remarkable ability to battle dangerous fungal infections

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

Moderna COVID-19 vaccine safe and efficacious in adolescents according to a new study

Moderna COVID-19 vaccine safe and efficacious in adolescents according to a new study

Sphingolipid profile could predict severity of heart disease in African American patients with lupus

Sphingolipid profile could predict severity of heart disease in African American patients with lupus

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.